Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 13,826 | 13,870 | 11,955 | 4,613 | 3,356 |
| Cost of Goods | 6,664 | 6,010 | 4,744 | 4,472 | N/A |
| Gross Profit | 7,162 | 7,850 | 4,511 | 141 | 3,356 |
| Operating Expenses | 7,848 | 4,690 | 744 | 472 | 0 |
| Operating Income | -22 | 3,180 | 7,211 | 141 | 3,356 |
| Other Income | 1,302 | 1,290 | -3,788 | -3,104 | 0 |
| Pre-tax Income | 1,280 | 4,470 | 3,423 | -2,963 | 3,356 |
| Income Tax | 31 | 120 | 79 | N/A | N/A |
| Net Income Continuous | 1,248 | 4,349 | 3,344 | -4,599 | -1,955 |
| Net Income | $-2,377 | $4,340 | $3,344 | $-2,849 | $-1,955 |
| EPS Basic Total Ops | -0.24 | 0.44 | 0.60 | -1.06 | -0.61 |
| EPS Basic Continuous Ops | 0.13 | 0.44 | 0.62 | -1.01 | -0.61 |
| EPS Diluted Total Ops | -0.23 | 0.40 | 0.44 | -1.06 | -0.61 |
| EPS Diluted Continuous Ops | 0.12 | 0.40 | 0.44 | -1.01 | -0.61 |
| EBITDA(a) | $756 | $3,940 | $7,211 | $141 | $3,356 |